# Heartburn, Gastroesophageal Reflux Disease

> **NCT07268820** · PHASE4 · RECRUITING · sponsor: **Incheon St.Mary's Hospital** · enrollment: 160 (estimated)

## Conditions studied

- GERD

## Interventions

- **DRUG:** Zastaprazan
- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT07268820
- **Lead sponsor:** Incheon St.Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-07
- **Primary completion:** 2026-05-29
- **Final completion:** 2026-09-30
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07268820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07268820, "Heartburn, Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07268820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*